A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)

This study has been completed.

Study NCT00279747 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: January 19, 2006 Last Updated: October 7, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	January 2003
Estimated Primary Completion Date:	No date given